Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

Clinical trial NCT01583283 · COMPLETED

Trial details

NCT number: NCT01583283
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2012-07-12
Primary completion: 2021-03-15
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.